ulrich medical USA Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported 2018 financial results which continue the company’s achievement of significant year-over-year organic growth for thirteen consecutive years (since 2006).
Including the year ending December 31, 2018, ulrich medical USA reported a 10-year milestone of 225% revenue growth in the U.S. market. In addition, the company also highlighted a 19% annual growth rate in U.S. surgical case volumes for 2018. This performance contributed to a notable 184% growth in U.S. case volumes between the years of 2008-2018.
“We want to express our sincere gratitude to our patients, our surgeons, and our industry partners for allowing us the privilege to serve them every day,” said Erika Laskey, Chief Commercial Officer, ulrich medical USA. “We are also extremely proud of our U.S. business results and we are grateful to our employees for their commitment to making our continued commercial success happen.”